Ortho Clinical Diagnostics Agrees to $6B Quidel Acquisition


San Diego, California-based Quidel Corporation and Raritan-based Ortho Clinical Diagnostics Holdings plc have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies, for $6 billion.

Transaction Benefits

  • Balanced and diversified product portfolio across diagnostic instruments and assays.
  • Highly synergistic opportunities create significant shareholder value creation.
  • Complementary cultures with a commitment to providing world-class products and services.
  • Robust, more diverse product pipeline and enhanced R&D capabilities.

To learn more go to New Jersey Business Magazine.